1. At the time this program was prepared, which of the following patients was an appropriate candidate for a COVID-19 booster injection?
A. 15-year-old girl with juvenile rheumatoid arthritis
B. 38-year-old nurse practicing in critical care who received a second dose of an mRNA vaccine 2 months previously
C. 45-year-old community pharmacist who received 1 dose of the Johnson & Johnson/Janssen vaccine 3 months previously
D. 18-year-old man with no comorbidities who received a second dose of an mRNA vaccine 7 months ago
E. Unsure
2. Which of the following COVID-19 vaccines tends to give the lowest increases in antibodies when used as a booster dose?
A. Bamlanivimab
B. Pfizer/BioNTech (BNT162b2)
C. Moderna (mRNA-1273)
D. Johnson & Johnson/Janssen vaccine (Ad26.COV2.S)
E. Unsure
3. Which of the following best describes data regarding COVID-19 vaccination in pregnant women?
A. COVID-19 vaccines should be avoided in pregnant women at this time.
B. Only mRNA vaccines should be administered to pregnant women.
C. COVID-19 vaccination may provide passive immunity to the child in utero.
D. Early data reveal a slightly higher miscarriage rate compared with baseline in pregnant women receiving the COVID-19 vaccine.
E. Unsure
4. Which of the following COVID-19 vaccines is now authorized for emergency use in children 5–11 years of age?
A. Moderna
B. Johnson & Johnson/Janssen
C. Merck
D. Pfizer/BioNTech
E. Unsure
5. Which of the following is TRUE regarding the initial data of the antiviral product Paxlovid?
A. The product works through integrase strand inhibition, similar to agents used in patients with HIV infection.
B. Paxlovid consists of 3 drugs used together for synergy against COVID-19.
C. The product has primarily been studied in patients presenting to the emergency department with COVID-19 symptoms.
D. In clinical trials, Paxlovid has been used within 5 days of laboratory-confirmed SARS-CoV-2 infection.
E. Unsure
Evaluation Questions
6. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
7. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
8. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
9. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
10. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
11. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Will the information presented cause you to change your practice?
A. Yes
B. No
16. Are you committed to making these changes?
A. Yes
B. No
17. As a result of this activity, did you learn something new?
A. Yes
B. No
18. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
19. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20